We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 204 results

  3. Eslicarbazepine acetate

    in Reactions Weekly
    Article 19 November 2022

  7. A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy

    Background and objectives

    Eslicarbazepine acetate (ESL) is a third-generation anti-seizure medication for patients with focal-onset epilepsy. There...

    Martin Hirsch, Ilka Immisch, ... Andreas Schulze-Bonhage in CNS Drugs
    Article Open access 03 November 2023

  8. Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational Study

    Background

    Eslicarbazepine acetate (ESL), a novel sodium channel blocker, is approved for mono and adjunctive treatment of partial epileptic seizures...

    Yaroslav Winter, Katharina Sandner, ... Sergiu Groppa in CNS Drugs
    Article Open access 30 September 2022

  11. Overnight switch from carbamazepine to eslicarbazepine in a real-life clinical scenario: a retrospective study

    Background

    Carbamazepine (CBZ) is a first-choice anti-seizure medication (ASM) whose efficacy is often invalidated by adverse effects (AEs)....

    Biagio Maria Sancetta, Lorenzo Ricci, ... Giovanni Assenza in Neurological Sciences
    Article 05 February 2024

  12. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures

    Eslicarbazepine acetate (Zebinix ® ), a voltage-gated sodium channel blocker, is a once-daily, orally administered anti-seizure medication available in...

    Young-A Heo in CNS Drugs
    Article 31 July 2020

  13. Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience

    Introduction

    The prevalence of epilepsy increases in elderly patients aged > 65 years, and treatment is challenging because clinical data are limited.

    ...
    Luís M. Magalhães, Raquel Costa, ... Patrício Soares-da-Silva in Drug Safety
    Article Open access 18 September 2021

  14. Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis

    Introduction

    The aim of this study was to compare healthcare resource utilization (HCRU) before and after initiation of eslicarbazepine acetate (ESL)...

    Darshan Mehta, Drishti Shah, ... Dana Saffel in Neurology and Therapy
    Article Open access 07 April 2021

  15. Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses

    Introduction

    This study assessed the association between early initiation of eslicarbazepine acetate (ESL) as first-line therapy (1L cohort) or as...

    Darshan Mehta, Matthew Davis, ... G. Rhys Williams in Neurology and Therapy
    Article Open access 19 September 2020

  16. Eslicarbazepine-acetate

    in Reactions Weekly
    Article 29 February 2020

  17. Eslicarbazepine acetate

    in Reactions Weekly
    Article 07 December 2019
Did you find what you were looking for? Share feedback.